Minii Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.50 M
- Revenue Growth -38.66%
- Profit Growth -52.87%
- Ebitda 111.37%
- Net Worth 7.26%
- Total Assets 20.68%
About Minii Life Sciences
Minii Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 December 2010 and has a history of 14 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tirupathi Byreddy and Padmaja Byreddy serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232KA2010PTC056081
-
Company No.
056081
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Dec 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Minii Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmaja Byreddy
|
Managing Director | 01-Dec-2010 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Tirupathi Byreddy
|
Director | 01-Dec-2010 | Current |
Financial Performance of Minii Life Sciences.
Minii Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 38.66% decrease. The company also saw a substantial fall in profitability, with a 52.87% decrease in profit. The company's net worth moved up by a moderate rise of 7.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Minii Life Sciences?
In 2020, Minii Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.50 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2014 | Hdfc Bank Limited | ₹1.50 M | Satisfied |
How Many Employees Work at Minii Life Sciences?
Unlock and access historical data on people associated with Minii Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Minii Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Minii Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.